Additionally, patients who exhibit TP53, PIK3CA, and ataxia telangiectasia-mutated (ATM) mutations are shown to respond better to ICIs, which may be a crucial factor to consider when analyzing a patient’s tumor profile [38]. Here, ATM is linked to neoplasm.